Breakthrough Therapy and the Hatch-Waxman Act

Bron Ferlas; Chris P/oenzke

首页> 外文期刊>U. S. pharmacist >Breakthrough Therapy and the Hatch-Waxman Act

【24h】

Breakthrough Therapy and the Hatch-Waxman Act

机译：突破性疗法和哈奇-瓦克斯曼法案

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The Drug Price Competition andPatent Term Restoration Act,also known as the Hatch-WaxmanAct, is a federal law passed in 1984 thatencourages the manufacture and marketentry of generic pharmaceuticals. Priorto 1984, antibiotics already had anabbreviated generic approval process inplace under section 505 of the FederalFood, Drug, and Cosmetic (FD&C)Act. In 1997, the Food and DrugAdministration Modernization Act madeantibiotics eligible for patent term res-toration under the Hatch-Waxman Act.

机译：《药品价格竞争和专利期限恢复法案》（又称《哈奇-瓦克斯曼法案》）是1984年通过的联邦法律，鼓励仿制药的生产和进入。 1984年以前，根据《联邦食品，药品和化妆品（FD＆C）法案》第505条，抗生素已经简化了通用批准程序。 1997年，根据《食品和药物管理局现代化法案》，根据《哈奇-瓦克斯曼法案》（Hatch-Waxman Act），抗生素有资格获得专利权。

著录项

来源
《U. S. pharmacist》 |2014年第supplajuna期|共4页
作者
Bron Ferlas; Chris P/oenzke;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Breakthrough Therapy and the Hatch-Waxman Act [J] . Bron Ferlas, Chris P/oenzke U. S. pharmacist . 2014,第SupplaJuna期

机译：突破性疗法和哈奇-瓦克斯曼法案
2. Chemotherapy, Biologic, and Immunotherapy Breakthroughs in Cancer Care [J] . Rojas Christine, Casablanca Yovanni Obstetrics and gynecology clinics of North America . 2019,第1期

机译：癌症护理中的化疗，生物疗法和免疫疗法突破
3. Olanzapine is an Inexpensive and Efficacious Agent for Breakthrough Chemotherapy Induced Acute Phase Vomiting Among Children Receiving Moderate or High Emetogenic Chemotherapy [J] . Kapoor G., Koneru S., Jain S. Pediatric blood & cancer . 2017,第Suppla3期

机译：Olanzapine是一种廉价而有效的突破化疗诱导诱导儿童急性期呕吐，接受中度或高均匀化疗的儿童
4. Interactions between Inter Partes Review and Hatch-Waxman Litigations [C] . Feng-Chi Chen, Pin-Shen Lee, Yun-Yu Huang, IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology . 2019

机译：当事人间审查与Hatch-Waxman诉讼之间的相互作用
5. Breakthrough Teams & Innovation in Orbit: Entrepreneurial Group Initiatives in Established Organizations [D] . Bonaccorsi, Richard. 2021

机译：突破轨道和创新轨道：既定组织中的企业群体举措
6. Breakthrough Candida krusei Fungemia during Fluconazole Prophylaxis followed by Breakthrough Zygomycosis during Caspofungin Therapy in a Patient with Severe Aplastic Anemia Who Underwent Stem Cell Transplantation [O] . Corrado Girmenia, Maria Luisa Moleti, Alessandra Micozzi, 2005

机译：严重再生障碍性贫血患者接受干细胞移植的氟康唑预防期间突破性克鲁斯念珠菌病随后卡泊芬净治疗期间突破性合子菌病
7. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomicosis during caspofungin therapy in a patients with severe aplastic anemia who underwent stem cell transplantation [O] . GIRMENIA C, MOLETI ML, MICOZZI A, 2005

机译：患有严重再生障碍性贫血的干细胞移植患者中，氟康唑预防期间突破了库氏假丝酵母菌菌血症，卡泊芬净治疗期间突破了zy虫病

Breakthrough Therapy and the Hatch-Waxman Act

摘要

著录项

相似文献

相关主题

期刊订阅